Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
(If this sounds dramatic, some patients report having no appetite at all, yet say their provider increases their dosage anyway)
Pediatrics 146 (1), e20192493
Key benefits Why people compare it 1 40-60% greater healing outcomes versus either peptide alone 2 Simultaneous activation of early-phase (TB-500) and mid-phase (BPC-157) repair 3 Synergistic upregulation of both VEGF/EGF and actin-migration pathways 4 Dual anti-inflammatory action: NO system modulation plus cytokine reduction 5 Single-vial reconstitution eliminates dosing variability 6 Optimized 1:1 mass ratio matching published combination protocols 7 Thorough tendon, ligament, muscle, and joint repair support 8 No emergent toxicity beyond individual component profiles Deep research About BPC-157 / TB-500 Blend This blend combines two structurally and mechanistically distinct peptides: BPC-157 (a 15-amino acid pentadecapeptide, MW ~1419 Da, sequence GEPPPGKPADDAGLV) and TB-500 (a synthetic 43-amino acid replica of Thymosin Beta-4, MW ~4921 Da)
Documented protocols direct the stream at the glass wall, not the powder direct pressure can shear peptide bonds
What to Do If Side Effects Worsen If side effects become severe or persistent, seek medical advice promptly
US$ 28.45
US$ 25.83
US$ 26.15
